Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Residual Histological Disease After Classification by Contemporary Non-Biopsy Treatment Pathways in Treatment-Naïve Chronic Hepatitis B: A Two-Center Retrospective Cohort Study

NCT07843446 is registered in ClinicalTrials.gov with Istanbul Medeniyet University as lead sponsor.

NCT NCT07843446
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07843446 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Residual Histological Disease After Classification by Contemporary Non-Biopsy Treatment Pathways in Treatment-Naïve Chronic Hepatitis B: A Two-Center Retrospective Cohort Study
Lead sponsor
Istanbul Medeniyet University
Phase
Observational
Overall status
Completed
Start date
January 20, 2026
Completion date
September 1, 2026
Enrollment
1,201 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

chronic hepatitis b